Related Experiment Video
Updated: Jul 31, 2025

Determining Ciliary Function and Membrane Impermeability of the Pseudostratified Lung Airway Epithelium
Published on: February 21, 2025
Mitochondria dysfunction in airway epithelial cells is associated with type 2-low asthma
Lu Zhao1,2, Jiali Gao1,2, Gongqi Chen1,2
1Division of Respiratory and Critical Care Medicine, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Mitochondria dysfunction contributes to Type 2-low asthma, a severe and corticosteroid-resistant form. This study identified key mitochondrial genes involved in T2-low asthma pathogenesis, offering potential therapeutic targets.
Area of Science:
- Pulmonary Medicine
- Molecular Biology
- Genetics
Background:
- Type 2-low asthma is a severe, corticosteroid-resistant asthma subtype.
- Airway epithelial cells and mitochondrial dysfunction are implicated in asthma pathogenesis.
- The specific role of epithelial mitochondrial dysfunction in Type 2-low asthma is not well understood.
Purpose of the Study:
- To investigate the role of epithelial mitochondrial dysfunction in Type 2-low asthma.
- To identify genes and pathways associated with mitochondrial dysfunction in Type 2-low asthma.
- To validate potential therapeutic targets for Type 2-low asthma.
Main Methods:
- Analysis of gene expression data from airway epithelial brushings of Type 2-high and Type 2-low asthma patients (GEO dataset GSE4302).
- Utilized Gene Set Enrichment Analysis (GSEA), Weighted Gene Co-expression Network Analysis (WGCNA), and protein-protein interaction (PPI) networks.
- Identified differentially expressed mitochondria-related genes (Mito-RGs) specific to Type 2-low asthma.
Main Results:
- Identified 692 differentially expressed genes (DEGs) between Type 2-high and Type 2-low asthma patients.
- GSEA indicated involvement of mitochondrial ATP synthesis and electron transport in Type 2-low asthma.
- Discovered 22 Type 2-low asthma-related mitochondrial DEGs, with five hub genes (ATP5G1, UQCR10, NDUFA3, TIMM10, NDUFAB1) identified and validated.
Conclusions:
- Epithelial mitochondrial dysfunction is a significant contributor to Type 2-low asthma.
- The identified hub genes represent potential biomarkers and therapeutic targets for Type 2-low asthma.
- Further research into mitochondrial pathways may reveal novel treatment strategies for severe asthma.
More Related Videos
14:48Flow Cytometric Isolation of Primary Murine Type II Alveolar Epithelial Cells for Functional and Molecular Studies
Published on: December 26, 2012
08:42Isolating Bronchial Epithelial Cells from Resected Lung Tissue for Biobanking and Establishing Well-Differentiated Air-Liquid Interface Cultures
Published on: May 26, 2023
Related Concept Videos
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...